LFSTLifeStance Health Group, Inc.

Nasdaq lifestance.com


$ 7.12 $ 0.14 (2.01 %)    

Thursday, 09-May-2024 15:59:56 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 7.12
$ 7.18
$ 0.00 x 0
$ 7.13 x 100
$ 6.73 - $ 7.33
$ 4.74 - $ 9.59
1,973,541
na
2.62M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-17-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lifestance-health-reiterated-fy24-revenue-of-119b-124b-vs-122b-est

2024 Guidance LifeStance is providing the following outlook for 2024: The Company is reiterating full year revenue of $1.19...

 lifestance-health-expects-q2-revenue-of-297m-315m-vs-30498m-est

2024 Guidance LifeStance is providing the following outlook for 2024: The Company is reiterating full year revenue of $1.19...

 lifestance-health-gr-q1-2024-gaap-eps-006-beats-008-estimate-sales-300437m-beat-298991m-estimate

LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of ...

 revenue-down-margins-up-lifeists-q1-financial-results-show-focus-on-premium-products-curbed-revenue-drop

Lifeist Wellness' Q1 2024 financial results, highlight a strategic shift towards higher-margin products and improved effici...

 morgan-stanley-reiterates-overweight-on-lifestance-health-gr-maintains-10-price-target

Morgan Stanley analyst Ricky Goldwasser reiterates LifeStance Health Gr (NASDAQ:LFST) with a Overweight and maintains $10 pr...

 lifeist-reports-highest-quarterly-gross-profit-in-history-continues-to-diversify-its-wellness-business

Lifeist Wellness Inc. reported on Monday its financial results for the three and 12 months ended Nov. 30, 2023. The Toronto-bas...

 jefferies-maintains-buy-on-lifestance-health-gr-raises-price-target-to-9

Jefferies analyst Brian Tanquilut maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $...

 goldman-sachs-maintains-neutral-on-lifestance-health-gr-raises-price-target-to-9

Goldman Sachs analyst Jamie Perse maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target fr...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 why-is-behavioral-health-focused-lifestance-health-stock-trading-higher-thursday

LifeStance Health reports 22% jump in Q4 2023 revenue of $280.60 million. Clinician base expands by 18%, visit volumes increase...

 advance-auto-parts-reports-q4-results-joins-bg-foods-vipshop-adt-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 lifestance-health-gr-q4-sales-28060m-beat-26300m-estimate-net-loss-of-45m-versus-loss-of-467m-a-year-ago

LifeStance Health Gr (NASDAQ:LFST) reported quarterly sales of $280.60 million which beat the analyst consensus estimate of $26...

 canadian-company-lifeist-says-farewell-to-cannabis-business-unit-turns-to-nutraceuticals

Canadian wellness company Lifeist has agreed to sell its CannMart cannabis subsidiaries to 1463663 B.C. for $3.72m. The deal, w...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION